Document is current
Any future updates will be listed below
-
Authors
Li, Meng
Li, Jun
Wang, Ying
Jiang, Guancheng
Jiang, Hanguo
Li, Mengdi
Zhu, Ziying
Ren, Fangli
Wang, Yinyin
Yan, Muyang
Chang, Zhijie https://orcid.org/0000-0003-1567-3227
-
Funding
Funding for this research was provided by:
Tsinghua University Spring Breeze Fund (20201080606)
Vanke Special Fund for Public Health and Health Discipline Development, Tsinghua University (2022Z82WKJ008)
- License Information
-
More Information
Article History
Received: 19 March 2024
Accepted: 3 December 2024
First Online: 18 December 2024
Declarations
:
: All experimental designs and protocols involving animals were approved by the Institutional Animal Care and Use Committee of Tsinghua University (Title of the approved project: Umbilical cord-derived mesenchymal stem cells preferentially modulate macrophages to alleviate pulmonary fibrosis. Approval Form ID: THU-LARC-2024-008. Date of IACUC approved: 2020/3/20) and complied with the recommendations of the academy’s animal research guidelines. The animal quality test batch number is BJVRL-WBKH-20200407A4. The experimental protocol was established, according to the ethical guidelines of the Helsinki Declaration and was approved by the Ethics Committee of Seventh Medical Center of Chinese PLA General Hospital (Title of the approved project: Umbilical cord and placental tissues and derivatives used in scientific studies of chronic inflammation in laboratory animals. Approval Form ID: 202200016. Date of IACUC approved: Jan 31, 2020). The patient(s) provided written informed consent for the use of samples. The inclusion and exclusion criteria for clinical umbilical cord and placenta samples are described in detail in the Additional file : Table S10.
: Not applicable.
: The authors declare no competing interests.
